Skip to main content

Trial closure: MAC8 and HEC1

Please be aware that two trials have recently been permenantly closed:
  1. MAC8 (NSABP B-37): A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Loco-Regional Relapse of Breast Cancer.
  2. HEC1 (CALGB 80802): Phase III Randomized Study of Sorafenib Plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC).
If you have any questions please contact Christine Bertrim, Trial Management Associate